151 related articles for article (PubMed ID: 12898475)
1. Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes.
Costa A; Fernández-Real JM; Vendrell J; Broch M; Casamitjana R; Ricart W; Conget I
Metabolism; 2003 Aug; 52(8):1068-71. PubMed ID: 12898475
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients.
Fernández-Real JM; Vendrell J; Ricart W; Broch M; Gutiérrez C; Casamitjana R; Oriola J; Richart C
Diabetes Care; 2000 Jun; 23(6):831-7. PubMed ID: 10841005
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus.
Hube F; Birgel M; Lee YM; Hauner H
Eur J Clin Invest; 1999 Aug; 29(8):672-8. PubMed ID: 10457150
[TBL] [Abstract][Full Text] [Related]
5. [Changes of leptin, tumor necrosis factor-alpha, neuropeptide Y levels and their association with insulin resistance and insulin secretion function in normal glucose tolerant first-degree relatives of familial type 2 diabetic pedigrees].
Ren Y; Li X; Tian H; Liang J; Zhang X; Yu H; Wang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1341-5. PubMed ID: 21374991
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.
Gupta A; Ten S; Anhalt H
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):75-82. PubMed ID: 15679072
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.
Straczkowski M; Kowalska I; Stepien A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I
Diabetes Care; 2002 Oct; 25(10):1824-8. PubMed ID: 12351485
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.
González-Sánchez JL; Martínez-Calatrava MJ; Martínez-Larrad MT; Zabena C; Fernández-Pérez C; Laakso M; Serrano-Ríos M
Clin Chem; 2006 Jan; 52(1):97-103. PubMed ID: 16254197
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
11. Association of tumor necrosis factor (TNF) promoter polymorphisms with plasma TNF-α levels and susceptibility to diabetic nephropathy in North Indian population.
Gupta S; Mehndiratta M; Kalra S; Kalra OP; Shukla R; Gambhir JK
J Diabetes Complications; 2015 Apr; 29(3):338-42. PubMed ID: 25704106
[TBL] [Abstract][Full Text] [Related]
12. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus.
Fernandez-Real JM; Lainez B; Vendrell J; Rigla M; Castro A; Peñarroja G; Broch M; Pérez A; Richart C; Engel P; Ricart W
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E952-9. PubMed ID: 11882518
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance.
Day CP; Grove J; Daly AK; Stewart MW; Avery PJ; Walker M
Diabetologia; 1998 Apr; 41(4):430-4. PubMed ID: 9562347
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
[TBL] [Abstract][Full Text] [Related]
15. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
16. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway.
Fernandez-Real JM; Broch M; Vendrell J; Ricart W
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1552-6. PubMed ID: 12975637
[TBL] [Abstract][Full Text] [Related]
17. Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects.
Kowalska I; Straczkowski M; Nikołajuk A; Krukowska A; Kinalska I; Górska M
Eur J Endocrinol; 2006 Feb; 154(2):319-24. PubMed ID: 16452547
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.
Ishii T; Hirose H; Saito I; Nishikai K; Maruyama H; Saruta T
Metabolism; 2000 Dec; 49(12):1616-8. PubMed ID: 11145126
[TBL] [Abstract][Full Text] [Related]
19. The tumour necrosis factor alpha -238 G --> A and -308 G --> A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II diabetic patients.
Koch M; Rett K; Volk A; Maerker E; Haist K; Weisser M; Rettig A; Renn W; Häring HU
Diabetologia; 2000 Feb; 43(2):181-4. PubMed ID: 10753039
[TBL] [Abstract][Full Text] [Related]
20. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
Ohara S; Komatsu R; Matsuyama T
Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
